نتائج البحث - "Goergen, Helen"

1

دورية أكاديمية

9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trial

المؤلفون: Gerhard-Hartmann, Elena, Goergen, Helen, Bröckelmann, Paul J., Mottok, Anja, Steinmüller, Tabea, Grund, Johanna, Zamò, Alberto, Ben-Neriah, Susana, Sasse, Stephanie, Borchmann, Sven, Fuchs, Michael, Borchmann, Peter, Reinke, Sarah, Engert, Andreas, Veldman, Johanna, Diepstra, Arjan, Klapper, Wolfram, Rosenwald, Andreas

مصطلحات موضوعية: ddc:610

وصف الملف: application/pdf

العلاقة: https://opus.bibliothek.uni-wuerzburg.de/frontdoor/index/index/docId/25835Test; urn:nbn:de:bvb:20-opus-258358; https://nbn-resolving.org/urn:nbn:de:bvb:20-opus-258358Test; https://doi.org/10.1111/bjh.17793Test; https://opus.bibliothek.uni-wuerzburg.de/files/25835/Gerhard_Hartmann_Haematol.pdfTest

الإتاحة: https://doi.org/10.1111/bjh.17793Test
https://opus.bibliothek.uni-wuerzburg.de/frontdoor/index/index/docId/25835Test
https://nbn-resolving.org/urn:nbn:de:bvb:20-opus-258358Test
https://opus.bibliothek.uni-wuerzburg.de/files/25835/Gerhard_Hartmann_Haematol.pdfTest

View record in BASE

2

دورية أكاديمية

Early Response to First-Line Anti–PD-1 Treatment in Hodgkin Lymphoma: A PET-Based Analysis from the Prospective, Randomized Phase II NIVAHL Trial

المؤلفون: Voltin, Conrad-Amadeus, Mettler, Jasmin, van Heek, Lutz, Goergen, Helen, Müller, Horst, Baues, Christian, Keller, Ulrich, Meissner, Julia, Trautmann-Grill, Karolin, Kerkhoff, Andrea, Bröckelmann, Paul J.

المساهمون: Voltin, Conrad-Amadeus, Mettler, Jasmin, van Heek, Lutz, Goergen, Helen, Müller, Horst, Baues, Christian, Keller, Ulrich, Meissner, Julia, Trautmann-Grill, Karolin, Kerkhoff, Andrea, Bröckelmann, Paul J.

العلاقة: https://resolver.sub.uni-goettingen.de/purl?gro-2/136286Test

الإتاحة: https://doi.org/10.1158/1078-0432.CCR-20-3303Test
https://resolver.sub.uni-goettingen.de/purl?gro-2/136286Test

View record in BASE

3

دورية أكاديمية

Histopathological growth patterns in patients with advanced nodular lymphocyte‐predominant Hodgkin lymphoma treated within the randomized HD18 study: a report from the German Hodgkin Study Group

المؤلفون: Eichenauer, Dennis A., Bühnen, Ina, Kreissl, Stefanie, Goergen, Helen, Fuchs, Michael, von Tresckow, Bastian, Rosenwald, Andreas, Klapper, Wolfram, Hansmann, Martin‐Leo, Möller, Peter, Bernd, Heinz‐Wolfram, Feller, Alfred C., Engert, Andreas, Borchmann, Peter, Hartmann, Sylvia

المساهمون: Deutsche Forschungsgemeinschaft

المصدر: British Journal of Haematology ; volume 196, issue 1, page 99-104 ; ISSN 0007-1048 1365-2141

الإتاحة: https://doi.org/10.1111/bjh.17770Test

View record in BASE

4

دورية أكاديمية

Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group

المؤلفون: Damaschin, Carla, Goergen, Helen, Kreissl, Stefanie, Plütschow, Annette, Breywisch, Frank, Mathas, Stephan, Meissner, Julia, Sökler, Martin, Topp, Max S., Vucinic, Vladan, Zimmermann, Andreas, von Tresckow, Bastian, Fuchs, Michael, Engert, Andreas, Borchmann, Peter, Eichenauer, Dennis A.

المصدر: http://lobid.org/resources/99370672770606441Test#!, 36(2):580-582.

مصطلحات موضوعية: Letter, Lymphoma, Clinical Trials, Phase II as Topic/statistics, Neoplasm Recurrence, Local/pathology [MeSH], Neoplasms, Second Primary/pathology [MeSH], Cyclophosphamide/administration, Etoposide/administration, Male [MeSH], Randomized Controlled Trials as Topic/statistics, Bleomycin/administration, Combination drug therapy, Vincristine/administration, Hodgkin Disease/pathology [MeSH], Adolescent [MeSH], Female [MeSH], Follow-Up Studies [MeSH], Hodgkin Disease/drug therapy [MeSH], Second Primary/drug therapy [MeSH], Adult [MeSH], Humans [MeSH], Middle Aged [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Survival Rate [MeSH], Prognosis [MeSH], Young Adult [MeSH], Brentuximab Vedotin/administration, Local/drug therapy [MeSH]

العلاقة: https://repository.publisso.de/resource/frl:6443794Test; https://doi.org/10.1038/s41375-021-01386-zTest; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807388Test/

الإتاحة: https://doi.org/10.1038/s41375-021-01386-zTest
https://repository.publisso.de/resource/frl:6443794Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807388Test/

View record in BASE

5

دورية أكاديمية

Non‐Hodgkin lymphoma after treatment for classical Hodgkin lymphoma: a report from the German Hodgkin Study Group

المؤلفون: Eichenauer, Dennis A., Müller, Horst, Elger, Leonard, Goergen, Helen, Fuchs, Michael, Kreissl, Stefanie, Böll, Boris, Diehl, Volker, von Tresckow, Bastian, Borchmann, Peter, Engert, Andreas

المصدر: British Journal of Haematology ; volume 193, issue 3, page 515-519 ; ISSN 0007-1048 1365-2141

الإتاحة: https://doi.org/10.1111/bjh.17327Test

View record in BASE

6

دورية أكاديمية

9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trial

المؤلفون: Gerhard‐Hartmann, Elena, Goergen, Helen, Bröckelmann, Paul J., Mottok, Anja, Steinmüller, Tabea, Grund, Johanna, Zamò, Alberto, Ben‐Neriah, Susana, Sasse, Stephanie, Borchmann, Sven, Fuchs, Michael, Borchmann, Peter, Reinke, Sarah, Engert, Andreas, Veldman, Johanna, Diepstra, Arjan, Klapper, Wolfram, Rosenwald, Andreas

المساهمون: Deutsche Krebshilfe

المصدر: British Journal of Haematology ; volume 196, issue 1, page 116-126 ; ISSN 0007-1048 1365-2141

الإتاحة: https://doi.org/10.1111/bjh.17793Test

View record in BASE

7

دورية أكاديمية

Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma ; The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial

المصدر: JAMA Oncology ; volume 6, issue 6, page 872 ; ISSN 2374-2437

الإتاحة: https://doi.org/10.1001/jamaoncol.2020.0750Test
https://jamanetwork.com/journals/jamaoncology/articlepdf/2765292/jamaoncology_brckelmann_2020_oi_200012.pdfTest

View record in BASE

8

دورية أكاديمية

Intensive treatment strategies in advanced-stage Hodgkin's lymphoma (HD9 and HD12): analysis of long-term survival in two randomised trials

المؤلفون: von Tresckow, Bastian, Kreissl, Stefanie, Goergen, Helen, Bröckelmann, Paul J, Pabst, Thomas, Fridrik, Michael, Rummel, Mathias, Jung, Wolfram, Thiemer, Julia, Sasse, Stephanie, Borchmann, Peter

المساهمون: von Tresckow, Bastian, Kreissl, Stefanie, Goergen, Helen, Bröckelmann, Paul J, Pabst, Thomas, Fridrik, Michael, Rummel, Mathias, Jung, Wolfram, Thiemer, Julia, Sasse, Stephanie, Borchmann, Peter

العلاقة: https://resolver.sub.uni-goettingen.de/purl?gro-2/133526Test; S2352302618301406

الإتاحة: https://doi.org/10.1016/S2352-3026Test(18)30140-6
https://resolver.sub.uni-goettingen.de/purl?gro-2/133526Test

View record in BASE

9

مؤتمر

B-CAP (brentuximab vedotin, cyclophosphamide, doxorubicin and predniso(lo)Ne) in Older Patients with Advanced-Stage Hodgkin Lymphoma: Results of a Phase II Intergroup Trial By the German Hodgkin Study Group (GHSG) and the Nordic Lymphoma Group (NLG)

المؤلفون: Boell, Boris, Fossa, Alexander, Goergen, Helen, Kamper, Peter, Leppa, Sirpa, Molin, Daniel, Meissner, Julia, Ritter, Ellen, Christensen, Jacob H., Hutchings, Martin, Fuchs, Michael, Engert, Andreas, Kobe, Carsten, Borchmann, Peter

المصدر: Boell , B , Fossa , A , Goergen , H , Kamper , P , Leppa , S , Molin , D , Meissner , J , Ritter , E , Christensen , J H , Hutchings , M , Fuchs , M , Engert , A , Kobe , C & Borchmann , P 2018 , ' B-CAP (brentuximab vedotin, cyclophosphamide, doxorubicin and predniso(lo)Ne) in Older Patients with Advanced-Stage Hodgkin Lymphoma: Results of a Phase II Intergroup Trial By the German Hodgkin Study Group (GHSG) and the Nordic Lymphoma Group (NLG) ' , Blood , vol. 132 ....

العلاقة: https://portal.findresearcher.sdu.dk/da/publications/fe46eb2d-96c3-45d2-9383-afbab5d252ccTest

الإتاحة: https://doi.org/10.1182/blood-2018-99-119363Test
https://portal.findresearcher.sdu.dk/da/publications/fe46eb2d-96c3-45d2-9383-afbab5d252ccTest

View record in BASE

10

دورية أكاديمية

Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma – Extended Follow‐up of 30 Patients Treated Within the CheckMate 205 Trial in a Single‐Center

المؤلفون: Momotow, Jesko, Goergen, Helen, Behringer, Karolin, Bröckelmann, Paul J., Borchmann, Sven, Tresckow, Bastian v., Kobe, Carsten, Engert, Andreas, Sasse, Stephanie

المساهمون: Bristol-Myers Squibb, Novartis, Meso Scale Diagnostics

المصدر: HemaSphere ; volume 3, issue 5 ; ISSN 2572-9241 2572-9241

الإتاحة: https://doi.org/10.1097/hs9.0000000000000293Test

View record in BASE

تنقيح النتائج